A61K 31/138
Aryloxyalkylamines
Official title: Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine (atenolol A61K31/165; pindolol A61K31/404; timolol A61K31/5377)
A61K31/138 (Aryloxyalkylamines) appears on 1,552 US grants and 3,098 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,552
- Published applications
- 3,098
- Assignees
- 1,250
- Inventors
- 4,413
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 4 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 8 | 0 |
| 1996 | 14 | 0 |
| 1997 | 28 | 0 |
| 1998 | 32 | 0 |
| 1999 | 24 | 0 |
| 2000 | 33 | 0 |
| 2001 | 42 | 13 |
| 2002 | 36 | 57 |
| 2003 | 35 | 95 |
| 2004 | 43 | 120 |
| 2005 | 15 | 87 |
| 2006 | 65 | 102 |
| 2007 | 9 | 88 |
| 2008 | 26 | 67 |
| 2009 | 20 | 82 |
| 2010 | 20 | 75 |
| 2011 | 29 | 103 |
| 2012 | 31 | 99 |
| 2013 | 45 | 110 |
| 2014 | 61 | 151 |
| 2015 | 70 | 178 |
| 2016 | 98 | 176 |
| 2017 | 80 | 164 |
| 2018 | 85 | 137 |
| 2019 | 88 | 142 |
| 2020 | 103 | 147 |
| 2021 | 71 | 199 |
| 2022 | 80 | 169 |
| 2023 | 55 | 151 |
| 2024 | 63 | 141 |
| 2025 | 81 | 133 |
| 2026 | 46 | 112 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods of treating lupus nephritis6 Oct 2026US 12,752,005 B2Genentech, Inc.
- Progesterone formulation to trigger ovulation and provide luteal phase support15 Sep 2026US 12,734,179 B2Augusta University Research Institute, Inc.
- Salt of a pharmaceutical compound1 Sep 2026US 12,721,826 B2Actimed Therapeutics Limited
- Methods and composition for modulating immune response and immune homeostasis11 Aug 2026US 12,702,696 B2Massachusetts Institute of Technology
- M-protein assays4 Aug 2026US 12,699,097 B2Bristol-Myers Squibb Company
- Combination therapy for treatment of depression8 Oct 2026US 2026/0306839 A1Flow Neuroscience, Inc.
- Compositions and methods for treating vulvar and vaginal atrophy (vva)1 Oct 2026US 2026/0294846 A1
- Trimetazidine solid phases1 Oct 2026US 2026/0294896 A1Les Laboratoires Servier
- Bupropion as a modulator of drug activity24 Sep 2026US 2026/0283980 A1Antecip Bioventures II LLC
- Bupropion as a modulator of drug activity24 Sep 2026US 2026/0283981 A1Antecip Bioventures II LLC
Most cited
By later US patents
- Therapeutic inhibitor of vascular smooth muscle cells562US 5,733,925 ANeoRx Corporation · 1998
- Therapeutic inhibitor of vascular smooth muscle cells438US 5,981,568 ANeoRx Corporation · 1999
- Sustained release, comfort formulation for glaucoma therapy329US 4,911,920 AAlcon Laboratories, Inc. · 1990
- Therapeutic inhibitor of vascular smooth muscle cells308US 6,074,659 ANoeRx Corporation · 2000
- Methods of indirectly stimulating the vagus nerve with an electrical field284US 6,778,854 B22004